Hu Yi-Yi-Li-Ge-Qi, Cao Sa-Li, Lin Long-Fei, Fu Jing, Dong Xiao-Xu, Yang Chun-Jing, Zhang Miao, Ni Jian
College of Traditional Mongolia Medicine and pharmacy, Inner Mongolia University for Nationalities, Tongliao 028000, China.
Beijing University of Chinese Medicine, Beijing 100029, China.
Zhongguo Zhong Yao Za Zhi. 2017 May;42(10):1964-1970. doi: 10.19540/j.cnki.cjcmm.20170307.003.
To establish HPLC-MS/MS method for simultaneous determination of daphnetin, daphnoretin, and daphneticin in rat plasma after oral and intravenous administration of Daphne giraldii extract, and then use them in the calculation of pharmacokinetic parameters. Six sprague-dawley rats received intragastric administration of D. giraldii extract (daphnetin, daphnoretin and daphneticin were 88.40, 3.24 and 4.28 mg•kg⁻¹, respectively). Their drug plasma concentration was determined by LC-MS/MS with schisandrin as an internal standard to draw plasma concentration-time curve. The pharmacokinetic parameters were calculated by Kinetica 4.4. The results showed that the linear range was 5-1 000 μg•L⁻¹ for daphnetin, daphnoretin and daphneticin, and the method ological test showed conformance to the requirements.The intraday and inter-day variable coefficients (RSD) were both less than 15.0%, indicating that both of legitimate precise and accuracy were consistent with the analysis requirements of biological samples. For daphnetin, the pharmacokinetic parameters Tmax, Cmax, AUC0-t, T1/2 and MRT were 4 h, 858.96 μg•L⁻¹, 10 566.4 μg•L⁻¹•h, 5.19 h and 9.43 h, respectively. For daphnoretin, the pharmacokinetic parameters Tmax, Cmax, AUC0-t, T1/2 and MRT were 2.92 h, 178.00 μg•L⁻¹, 905.89 μg•L⁻¹•h, 3.50 h and 6.95 h, respectively. For daphneticin, the pharmacokinetic parameters Tmax, Cmax, AUC0-t, T1/2 and MRT were 2 h, 36.67 μg•L⁻¹, 355.11 μg•L⁻¹•h, 4.95 h and 8.27 h, respectively. The LC-MS/MS analysis method established in this study was proved to be so accurate and sensitive that it can be applied to the pharmacokinetic study of daphnetin, daphnoretin and daphneticin.
建立高效液相色谱-串联质谱(HPLC-MS/MS)法同时测定大鼠口服及静脉注射祖师麻提取物后血浆中瑞香素、瑞香苷和瑞香新苷的含量,并用于药代动力学参数计算。6只Sprague-Dawley大鼠灌胃给予祖师麻提取物(瑞香素、瑞香苷和瑞香新苷分别为88.40、3.24和4.28 mg•kg⁻¹)。以五味子醇甲为内标,采用LC-MS/MS法测定其血浆药物浓度,绘制血浆浓度-时间曲线。采用Kinetica 4.4计算药代动力学参数。结果表明,瑞香素、瑞香苷和瑞香新苷的线性范围为5-1 000 μg•L⁻¹,方法学考察符合要求。日内和日间变异系数(RSD)均小于15.0%,表明精密度和准确度均符合生物样品分析要求。瑞香素的药代动力学参数Tmax、Cmax、AUC0-t、T1/2和MRT分别为4 h、858.96 μg•L⁻¹、10 566.4 μg•L⁻¹•h、5.19 h和9.43 h。瑞香苷的药代动力学参数Tmax、Cmax、AUC0-t、T1/2和MRT分别为2.92 h、178.00 μg•L⁻¹、905.89 μg•L⁻¹•h、3.50 h和6.95 h。瑞香新苷的药代动力学参数Tmax、Cmax、AUC0-t、T1/2和MRT分别为2 h、36.67 μg•L⁻¹、355.11 μg•L⁻¹•h、4.95 h和8.27 h。本研究建立的LC-MS/MS分析方法准确、灵敏,可用于瑞香素、瑞香苷和瑞香新苷的药代动力学研究。